146 related articles for article (PubMed ID: 36566750)
1. Ethnic-Associated Phenotype Variations in Moyamoya Cerebrovascular Outcomes.
Unda SR; Antoniazzi AM; Fluss R; Yassari N; Esenwa C; Haranhalli N; Altschul DJ
Cerebrovasc Dis; 2023; 52(5):519-525. PubMed ID: 36566750
[TBL] [Abstract][Full Text] [Related]
2. Moyamoya Disease and Syndrome: A National Inpatient Study of Ischemic Stroke Predictors.
Unda SR; Antoniazzi AM; Miller R; Klyde D; Javed K; Fluss R; Holland R; De la Garza Ramos R; Haranhalli N; Altschul DJ
J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105965. PubMed ID: 34247053
[TBL] [Abstract][Full Text] [Related]
3. Differing Surgical Outcomes in a Multiethnic Cohort Suggest Racial Phenotypes in Moyamoya Disease.
Feghali J; Xu R; Yang W; Liew J; Tamargo RJ; Marsh EB; Huang J
World Neurosurg; 2019 Aug; 128():e865-e872. PubMed ID: 31082553
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Radiological Features of Childhood Onset Adult Moyamoya Disease: Implication for Hemorrhagic Stroke.
Yamamoto S; Kashiwazaki D; Uchino H; Saito H; Akioka N; Kuwayama N; Kuroda S
Neurol Med Chir (Tokyo); 2020 Jul; 60(7):360-367. PubMed ID: 32536657
[TBL] [Abstract][Full Text] [Related]
5. Distinct Clinical and Radiographic Phenotypes in Pediatric Patients With Moyamoya.
Kaseka ML; Slim M; Muthusami P; Dirks PB; Westmacott R; Kassner A; Bhathal I; Williams S; Shroff M; Logan W; Moharir M; MacGregor DL; Pulcine E; deVeber GA; Dlamini N
Pediatr Neurol; 2021 Jul; 120():18-26. PubMed ID: 33962345
[TBL] [Abstract][Full Text] [Related]
6. Disparities in the symptomatic presentation of Moyamoya disease in the United States: A nationwide all-payer analysis.
Fuentes AM; Chiu RG; Mehta AI
J Clin Neurosci; 2021 May; 87():92-96. PubMed ID: 33863543
[TBL] [Abstract][Full Text] [Related]
7. Five-Year Stroke Risk and Its Predictors in Asymptomatic Moyamoya Disease: Asymptomatic Moyamoya Registry (AMORE).
Kuroda S; Yamamoto S; Funaki T; Fujimura M; Kataoka H; Hishikawa T; Takahashi J; Endo H; Nariai T; Osato T; Saito N; Sato N; Hori E; Ito YM; Miyamoto S;
Stroke; 2023 Jun; 54(6):1494-1504. PubMed ID: 37216455
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Arterial Ischemic and Hemorrhagic Pediatric Stroke in Etiology, Risk Factors, Clinical Manifestations, and Prognosis.
Pangprasertkul S; Borisoot W; Buawangpong N; Sirikul W; Wiwattanadittakul N; Katanyuwong K; Sanguansermsri C
Pediatr Emerg Care; 2022 Sep; 38(9):e1569-e1573. PubMed ID: 35113509
[TBL] [Abstract][Full Text] [Related]
9. Transient Ischemic Attack in Pediatric Patients With Moyamoya Disease: Clinical Features, Natural History, and Predictors of Stroke.
Zhao M; Zhang D; Wang S; Zhang Y; Wang R; Zhao J
Pediatr Neurol; 2017 Oct; 75():48-54. PubMed ID: 28778481
[TBL] [Abstract][Full Text] [Related]
10. Arterial Ischemic Stroke in Moyamoya Patients Who Underwent Vaginal Delivery and Cesarean Section.
Antoniazzi AM; Unda SR; Khatri D; Holland R; De la Garza Ramos R; Haranhalli N; Altschul DJ
World Neurosurg; 2022 Jul; 163():e391-e395. PubMed ID: 35421589
[TBL] [Abstract][Full Text] [Related]
11. High Prevalence of Moyamoya Syndrome in Appalachia.
Nisiewicz MJ; Roberts JM; Dobbs MR; Ajadi EA; Kitzman P; Wolfe M; Elkins K; Dugan AJ; Fraser JF
Cerebrovasc Dis; 2020; 49(5):516-521. PubMed ID: 33027801
[TBL] [Abstract][Full Text] [Related]
12. Pediatric stroke among Hong Kong Chinese subjects.
Chung B; Wong V
Pediatrics; 2004 Aug; 114(2):e206-12. PubMed ID: 15286258
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Stroke Risk Factors between Symptomatic and Asymptomatic Patients in a North American Moyamoya Disease Cohort.
Kumar M; Larson A; Jabal MS; Rinaldo L; Savastano L; Lanzino G; Meyer F; Lehman V; Klaas J
Cerebrovasc Dis Extra; 2022; 12(2):72-75. PubMed ID: 35588715
[TBL] [Abstract][Full Text] [Related]
14. Surgical outcomes and predictors of stroke in a North American white and African American moyamoya population.
Mallory GW; Bower RS; Nwojo ME; Taussky P; Wetjen NM; Varzoni TC; Hanel RA; Meyer FB
Neurosurgery; 2013 Dec; 73(6):984-91; discussion 981-2. PubMed ID: 24030171
[TBL] [Abstract][Full Text] [Related]
15. A Magnetic Resonance Angiography-Based Study Comparing Machine Learning and Clinical Evaluation: Screening Intracranial Regions Associated with the Hemorrhagic Stroke of Adult Moyamoya Disease.
Yin HL; Jiang Y; Huang WJ; Li SH; Lin GW
J Stroke Cerebrovasc Dis; 2022 Apr; 31(4):106382. PubMed ID: 35183983
[TBL] [Abstract][Full Text] [Related]
16. Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events.
Dobson SR; Holden KR; Nietert PJ; Cure JK; Laver JH; Disco D; Abboud MR
Blood; 2002 May; 99(9):3144-50. PubMed ID: 11964276
[TBL] [Abstract][Full Text] [Related]
17. Trends in hospitalizations and epidemiological characteristics of adults Moyamoya disorder in the United States.
Patel SD; Desai N; Rane S; Patel N; Desai R; Mehta T; Ollenschleger MD; Nanda A; Starke RM; Khandelwal P
J Neurol Sci; 2020 Dec; 419():117165. PubMed ID: 33059298
[TBL] [Abstract][Full Text] [Related]
18. Impact of cortical hemodynamic failure on both subsequent hemorrhagic stroke and effect of bypass surgery in hemorrhagic moyamoya disease: a supplementary analysis of the Japan Adult Moyamoya Trial.
Takahashi JC; Funaki T; Houkin K; Kuroda S; Fujimura M; Tomata Y; Miyamoto S
J Neurosurg; 2020 Mar; 134(3):940-945. PubMed ID: 32168484
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors and Imaging Biomarkers Associated With Perioperative Stroke in Pediatric Moyamoya Arteriopathy.
Gardner Yelton SE; Gatti J; Adil M; Guryildirim M; Tekes A; Sun LR
J Child Neurol; 2022 Dec; 37(12-14):963-969. PubMed ID: 36128779
[TBL] [Abstract][Full Text] [Related]
20. Ischemic Stroke in Young Adults with Moyamoya Disease: Prognostic Factors for Stroke Recurrence and Functional Outcome after Revascularization.
Zhao M; Deng X; Gao F; Zhang D; Wang S; Zhang Y; Wang R; Zhao J
World Neurosurg; 2017 Jul; 103():161-167. PubMed ID: 28408257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
